Mastocytosis - An update;Mastozytose - Aktueller Stand

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 9, 2010, Pages 695-712

  Amon, Ulrich ^a   Hartmann, Karin ^b   Horny, Hans Peter ^c   Nowak, Anna ^a   Simon, Jan C ^d  

^a PsoriSol Clinic for Dermatology   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Institute of Pathology   (Germany)

^d NONE

Author keywords

activating mutation Kit D816V; mastocytosis; review; tryptase; WHO classification

Indexed keywords

ADRENALIN; ALPHA INTERFERON; ALPHA2B INTERFERON; CLADRIBINE; DASATINIB; GLUCOCORTICOID; IMATINIB; MIDOSTAURIN; NILOTINIB; TRYPTASE;

ANAPHYLAXIS; BONE MARROW BIOPSY; CELL INFILTRATION; CODON; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEALTH CARE QUALITY; HUMAN; INSECT STING; LIFE EXPECTANCY; MAST CELL; MASTOCYTOMA; MASTOCYTOSIS; MEDIATOR RELEASE; MEDICAL CARE; PATHOGENESIS; POINT MUTATION; PRACTICE GUIDELINE; PRURITUS; REMISSION; REVIEW; SKIN BIOPSY; URTICARIA;

ADULT; ANTINEOPLASTIC AGENTS; BIOPSY; CHILD; CHRONIC DISEASE; CLADRIBINE; CODON; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; IMMUNOLOGIC FACTORS; INFANT; INTERFERON-ALPHA; MAST CELLS; MASTOCYTOSIS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN;

EID: 77956153867     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07482.x     Document Type: Review

References (14)

1. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference report of "Year 2000 Working Conference on Mastocytosis". Leuk Res 2001 25 : 603 625.
2. Hartmann K, Biedermann T, Brockow K, Grabbe J, Horny HP, Lippert U, Maurer M, Raithel M, Rietschel E, Ruëff F und Sotlar K für das Kompetenznetzwerk Mastozytose e.V. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und der Deutschen Dermatologischen Gesellschaft (DDG). Allergologie 2009 32 : 199 213 Erstpublikation am 20.11.2008 online auf der Homepage der Ar-beitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) : http://www.uni-duesseldorf.de/AWMF/II/013-058.htm
3. Metcalfe DD. Mast cells and mastocytosis. Blood 2008 112 : 946 956.
4. Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A. Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One 2008 3 : e2266.
5. Valent P, Akin C, Sperr WR, Mayerhofer M, Födinger M, Fritsche-Polanz R, Sotlar K, Escribano L, Arock M, Horny HP, Metcalfe DD. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005 46 : 35 48.
6. Orfao A, Garcia-Montero AC, Sanchez L, Escribano L REMA. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007 138 : 12 30.
7. Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj-Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010 130 : 804 815.
8. Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009 113 : 5727 5736.
9. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008 63 : 226 232.
10. Sotlar K, Escribano L, Landt O, Möhrle S, Herrero S, Torrelo A, Lass U, Horny HP, Bültmann B. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003 162 : 737 746.
11. Ruëff F, Dugas-Breit S, Przybilla B. Stinging Hymenoptera and mastocytosis. Curr Opin Allergy Clin Immunol 2009 9 : 338 342.
12. Lim KH, Pardanani A, Butterfield JH, Li CY, Tefferi A. Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol 2009 84 : 790 794.
13. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004 103 : 3222 3225.
14. Gotlib J, George TI, Corless C et al. The KIT tyrosine kinase inhibitor midostaurine (PKC412) exhibits a high response rate in aggressive systemic mastocytosis: Interim results of a phase II trial. Blood 2007 110 : Abstract 3536